These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
95 related articles for article (PubMed ID: 16508329)
21. Clinical utility of insulin-like growth factor-I (IGF-I) and IGF binding protein-3 measurements in paediatric practice. Banerjee I; Clayton PE Pediatr Endocrinol Rev; 2006 Jun; 3(4):393-402. PubMed ID: 16816808 [TBL] [Abstract][Full Text] [Related]
22. Growth without growth hormone receptor: estradiol is a major growth hormone-independent regulator of hepatic IGF-I synthesis. Venken K; Schuit F; Van Lommel L; Tsukamoto K; Kopchick JJ; Coschigano K; Ohlsson C; Movérare S; Boonen S; Bouillon R; Vanderschueren D J Bone Miner Res; 2005 Dec; 20(12):2138-49. PubMed ID: 16294267 [TBL] [Abstract][Full Text] [Related]
23. Treatment of insulin-like growth factor deficiency with IGF-I: studies in humans. Backeljauw PF; Chernausek SD Horm Res; 2006; 65 Suppl 1():21-7. PubMed ID: 16508330 [No Abstract] [Full Text] [Related]
24. Intrauterine growth retardation and postnatal growth failure associated with deletion of the insulin-like growth factor I gene. Woods KA; Camacho-Hübner C; Savage MO; Clark AJ N Engl J Med; 1996 Oct; 335(18):1363-7. PubMed ID: 8857020 [No Abstract] [Full Text] [Related]
25. Evaluation of insulin-like growth factor-1 and insulinlike growth factor binding protein-3 in diagnosis of growth hormone deficiency in short-stature children. Ali A; Hashim R; Khan FA; Sattar A; Ijaz A; Manzoor SM; Younas M J Ayub Med Coll Abbottabad; 2009; 21(3):40-5. PubMed ID: 20929010 [TBL] [Abstract][Full Text] [Related]
26. NO plays a role in LPS-induced decreases in circulating IGF-I and IGFBP-3 and their gene expression in the liver. Priego T; Ibáñez de Cáceres I; Martín AI; Villanúa MA; López-Calderón A Am J Physiol Endocrinol Metab; 2004 Jan; 286(1):E50-6. PubMed ID: 13129855 [TBL] [Abstract][Full Text] [Related]
27. Studies of gene expression in liver of insulin-like growth factor (IGF)-I, IGF binding protein-3 and growth hormone (GH) receptor/GH binding protein in rats treated neonatally with monosodium glutamate. Kubota A; Nakagawa Y; Igarashi Y Horm Metab Res; 1994 Nov; 26(11):497-503. PubMed ID: 7533119 [TBL] [Abstract][Full Text] [Related]
28. Short stature and decreased insulin-like growth factor I (IGF-I)/growth hormone (GH)-ratio in an adult GH-deficient patient pointing to additional partial GH insensitivity due to a R179C mutation of the growth hormone receptor. Meyer S; Ipek M; Keth A; Minnemann T; von Mach MA; Weise A; Ittner JR; Nawroth PP; Plöckinger U; Stalla GK; Tuschy U; Weber MM; Kann PH; ; Growth Horm IGF Res; 2007 Aug; 17(4):307-14. PubMed ID: 17462934 [TBL] [Abstract][Full Text] [Related]
29. Regulation of local synthesis of insulin-like growth factor-I and binding proteins in mammary tissue. Weber MS; Purup S; Vestergaard M; Akers RM; Sejrsen K J Dairy Sci; 2000 Jan; 83(1):30-7. PubMed ID: 10659960 [TBL] [Abstract][Full Text] [Related]
30. Hepatic growth hormone receptor, insulin-like growth factor I, and insulin-like growth factor-binding protein messenger RNA expression in pediatric liver disease. Holt RI; Crossey PA; Jones JS; Baker AJ; Portmann B; Miell JP Hepatology; 1997 Dec; 26(6):1600-6. PubMed ID: 9398004 [TBL] [Abstract][Full Text] [Related]
31. Growth retardation in constitutionally short children is related both to low serum levels of insulin-like growth factor-I and to its reduced bioavailability. Lindgren BF; Segovia B; Lassarre C; Binoux M; Gourmelen M Growth Regul; 1996 Sep; 6(3):158-64. PubMed ID: 8894649 [TBL] [Abstract][Full Text] [Related]
32. Prostate cancer risk in relation to selected genetic polymorphisms in insulin-like growth factor-I, insulin-like growth factor binding protein-3, and insulin-like growth factor-I receptor. Chen C; Freeman R; Voigt LF; Fitzpatrick A; Plymate SR; Weiss NS Cancer Epidemiol Biomarkers Prev; 2006 Dec; 15(12):2461-6. PubMed ID: 17164371 [TBL] [Abstract][Full Text] [Related]
33. Pathophysiology, assessment and management of the child with growth hormone resistance. Savage MO; Cohen L; Cohen AJ; Cohen P; Saenger PH Pediatr Endocrinol Rev; 2010 Jun; 7(4):347-56. PubMed ID: 20679995 [TBL] [Abstract][Full Text] [Related]
35. STAT5B deficiency: Impacts on human growth and immunity. Hwa V Growth Horm IGF Res; 2016 Jun; 28():16-20. PubMed ID: 26703237 [TBL] [Abstract][Full Text] [Related]
36. Is there a medical need to explore the clinical use of insulin-like growth factor I? Savage MO; Camacho-Hübner C; Dunger DB; Ranke MB; Ross RJ; Rosenfeld RG Growth Horm IGF Res; 2001 Jun; 11 Suppl A():S65-9. PubMed ID: 11527091 [TBL] [Abstract][Full Text] [Related]
37. Growth hormone, insulin-like growth factor I, and growth: local knowledge. Frank SJ Endocrinology; 2007 Apr; 148(4):1486-8. PubMed ID: 17369499 [No Abstract] [Full Text] [Related]
38. IGF-I deficiency, longevity and cancer protection of patients with Laron syndrome. Laron Z; Kauli R; Lapkina L; Werner H Mutat Res Rev Mutat Res; 2017; 772():123-133. PubMed ID: 28528685 [TBL] [Abstract][Full Text] [Related]
39. A novel dominant negative mutation in the intracellular domain of GHR is associated with growth hormone insensitivity. Takagi M; Shinohara H; Nagashima Y; Hasegawa Y; Narumi S; Hasegawa T Clin Endocrinol (Oxf); 2016 Oct; 85(4):669-71. PubMed ID: 27234692 [No Abstract] [Full Text] [Related]
40. Molecular defects in the growth hormone-IGF axis. Lee J; Menon RK Indian J Pediatr; 2005 Feb; 72(2):145-8. PubMed ID: 15758538 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]